4911 Stock Overview
G&E Herbal Biotechnology Co., Ltd., a biopharmaceutical company, focuses on the development and commercialization of novel botanical extraction technology and products.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 4911 from our risk checks.
G&E Herbal Biotechnology Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$59.50 |
52 Week High | NT$83.50 |
52 Week Low | NT$53.00 |
Beta | -0.071 |
1 Month Change | -0.50% |
3 Month Change | -0.34% |
1 Year Change | -23.13% |
3 Year Change | 110.62% |
5 Year Change | 38.37% |
Change since IPO | 11.51% |
Recent News & Updates
Shareholder Returns
4911 | TW Personal Products | TW Market | |
---|---|---|---|
7D | 1.5% | -0.2% | 1.3% |
1Y | -23.1% | -16.0% | 29.2% |
Return vs Industry: 4911 underperformed the TW Personal Products industry which returned -16% over the past year.
Return vs Market: 4911 underperformed the TW Market which returned 29.2% over the past year.
Price Volatility
4911 volatility | |
---|---|
4911 Average Weekly Movement | 3.0% |
Personal Products Industry Average Movement | 4.0% |
Market Average Movement | 4.8% |
10% most volatile stocks in TW Market | 8.7% |
10% least volatile stocks in TW Market | 2.3% |
Stable Share Price: 4911 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4911's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2002 | 37 | n/a | www.geherbs.com.tw |
G&E Herbal Biotechnology Co., Ltd., a biopharmaceutical company, focuses on the development and commercialization of novel botanical extraction technology and products. It offers botanical anti-aging cosmetic products, such as facial foam cleanser and cleansing essence, botanical extract toner, lightening lotion, essential oil, and moisturizing serum and cream; SR-100 botanical essence and bromelain illuminating cleansing mousse; and hepato protective agent capsules. The company also provides botanical healthcare products comprising ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules; and adult products.
G&E Herbal Biotechnology Co., Ltd. Fundamentals Summary
4911 fundamental statistics | |
---|---|
Market cap | NT$3.31b |
Earnings (TTM) | NT$72.40m |
Revenue (TTM) | NT$181.44m |
45.7x
P/E Ratio18.3x
P/S RatioIs 4911 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4911 income statement (TTM) | |
---|---|
Revenue | NT$181.44m |
Cost of Revenue | NT$36.86m |
Gross Profit | NT$144.59m |
Other Expenses | NT$72.19m |
Earnings | NT$72.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 1.30 |
Gross Margin | 79.69% |
Net Profit Margin | 39.90% |
Debt/Equity Ratio | 0% |
How did 4911 perform over the long term?
See historical performance and comparison